Is Losartan (angiotensin II receptor blocker) used to treat hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Losartan is an Effective Medication for Hypertension

Yes, losartan (an angiotensin II receptor blocker) is definitively used to treat hypertension and is FDA-approved for this indication. 1

Indications and Mechanism

  • Losartan is specifically indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older to lower blood pressure 1
  • As an angiotensin II receptor blocker (ARB), losartan works by selectively blocking the binding of angiotensin II to the AT1 receptors, thereby preventing the vasoconstriction and aldosterone-secreting effects of angiotensin II 2
  • Losartan has been shown to effectively lower blood pressure, with reductions comparable to other antihypertensive medications such as enalapril, atenolol, and felodipine 3

Clinical Benefits Beyond Blood Pressure Control

  • Losartan reduces the risk of stroke in patients with hypertension and left ventricular hypertrophy, though this benefit may not apply to Black patients 1
  • In the LIFE study, losartan demonstrated a lower risk for cardiovascular endpoints (RR: 0.76) and all-cause mortality (RR: 0.61) compared to atenolol in patients with hypertension and left ventricular hypertrophy 4, 5
  • Losartan is particularly beneficial for patients with type 2 diabetes and nephropathy, as it reduces the rate of progression of kidney disease 1, 6

Special Populations and Considerations

  • In patients with type 2 diabetes and nephropathy, losartan significantly reduced the incidence of doubling of serum creatinine, end-stage kidney disease, and death by 16% compared to placebo in the RENAAL trial 4
  • Losartan is especially effective in patients with albuminuria, as it provides renoprotective effects beyond blood pressure control 4, 6
  • For elderly patients with hypertension, losartan has shown similar efficacy to other antihypertensive agents and is generally well-tolerated 7

Dosing and Administration

  • Treatment typically begins with a low dose and can be titrated up to the highest approved dose the patient can tolerate 4
  • Losartan may be administered with or without food 1
  • If blood pressure goals are not achieved with losartan monotherapy, additional antihypertensive medications may be added 5, 1

Safety Profile and Monitoring

  • Losartan is generally well-tolerated with an overall incidence of adverse events similar to that of placebo 1, 3
  • Common side effects include dizziness (3% vs. 2% with placebo), upper respiratory infection, nasal congestion, and back pain 1
  • Unlike ACE inhibitors, losartan is associated with a significantly lower incidence of cough 1
  • Monitoring of renal function and serum potassium is recommended, especially in patients with pre-existing renal impairment 4, 5
  • Losartan is contraindicated during pregnancy as it can cause harm or death to an unborn baby 1

Practical Considerations

  • Losartan can be used as monotherapy or in combination with other antihypertensive agents, particularly thiazide diuretics for enhanced efficacy 1, 3
  • Many patients will require more than one drug to achieve blood pressure goals 1
  • Target blood pressure should be <130/80 mmHg for patients with diabetes or chronic kidney disease 4, 5

Losartan represents an important option in the management of hypertension, particularly for patients with comorbidities such as left ventricular hypertrophy, type 2 diabetes, or kidney disease.

References

Research

Efficacy and safety of losartan.

The Canadian journal of cardiology, 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Losartan Therapy for Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Losartan in diabetic nephropathy.

Expert review of cardiovascular therapy, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.